{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,28]],"date-time":"2026-03-28T02:54:55Z","timestamp":1774666495214,"version":"3.50.1"},"reference-count":103,"publisher":"Elsevier","isbn-type":[{"value":"9780323988513","type":"print"}],"license":[{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100011892","name":"Kaohsiung Chang Gung Memorial Hospital","doi-asserted-by":"publisher","award":["107-2314-B-182A-130"],"award-info":[{"award-number":["107-2314-B-182A-130"]}],"id":[{"id":"10.13039\/501100011892","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100011892","name":"Kaohsiung Chang Gung Memorial Hospital","doi-asserted-by":"publisher","award":["MOST 107-2314-B-182A-123"],"award-info":[{"award-number":["MOST 107-2314-B-182A-123"]}],"id":[{"id":"10.13039\/501100011892","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100011892","name":"Kaohsiung Chang Gung Memorial Hospital","doi-asserted-by":"publisher","award":["MOST 108-2314-B-182A-072"],"award-info":[{"award-number":["MOST 108-2314-B-182A-072"]}],"id":[{"id":"10.13039\/501100011892","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004663","name":"Ministry of Science and Technology, Taiwan","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004663","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2022]]},"DOI":"10.1016\/bs.acc.2022.03.006","type":"book-chapter","created":{"date-parts":[[2022,4,18]],"date-time":"2022-04-18T07:30:35Z","timestamp":1650267035000},"page":"185-212","source":"Crossref","is-referenced-by-count":15,"title":["Orexin\/hypocretin and major psychiatric disorders"],"prefix":"10.1016","member":"78","reference":[{"issue":"1","key":"10.1016\/bs.acc.2022.03.006_bb0010","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1073\/pnas.95.1.322","article-title":"The hypocretins: hypothalamus-specific peptides with neuroexcitatory activity","volume":"95","author":"de Lecea","year":"1998","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"5","key":"10.1016\/bs.acc.2022.03.006_bb0015","article-title":"Orexins and orexin receptors: a family of hypothalamic neuropeptides and G protein-coupled receptors that regulate feeding behavior","volume":"92","author":"Sakurai","year":"1998","journal-title":"Cell"},{"key":"10.1016\/bs.acc.2022.03.006_bb0020","doi-asserted-by":"crossref","first-page":"357","DOI":"10.3389\/fphys.2017.00357","article-title":"Orexin system: the key for a healthy life","volume":"8","author":"Chieffi","year":"2017","journal-title":"Front. Physiol."},{"issue":"12","key":"10.1016\/bs.acc.2022.03.006_bb0025","doi-asserted-by":"crossref","first-page":"2413","DOI":"10.1016\/j.cellsig.2013.07.025","article-title":"Orexin receptors: multi-functional therapeutic targets for sleeping disorders, eating disorders, drug addiction, cancers and other physiological disorders","volume":"25","author":"Xu","year":"2013","journal-title":"Cell. Signal."},{"issue":"1\u20132","key":"10.1016\/bs.acc.2022.03.006_bb0030","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/S0014-5793(98)01266-6","article-title":"Distribution of orexin receptor mRNA in the rat brain","volume":"438","author":"Trivedi","year":"1998","journal-title":"FEBS Lett."},{"issue":"19","key":"10.1016\/bs.acc.2022.03.006_bb0035","doi-asserted-by":"crossref","first-page":"10911","DOI":"10.1073\/pnas.96.19.10911","article-title":"Orexin a activates locus coeruleus cell firing and increases arousal in the rat","volume":"96","author":"Hagan","year":"1999","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"4","key":"10.1016\/bs.acc.2022.03.006_bb0040","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1016\/S0092-8674(00)81973-X","article-title":"Narcolepsy in orexin knockout mice: molecular genetics of sleep regulation","volume":"98","author":"Chemelli","year":"1999","journal-title":"Cell"},{"issue":"3","key":"10.1016\/bs.acc.2022.03.006_bb0045","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1016\/S0092-8674(00)81965-0","article-title":"The sleep disorder canine narcolepsy is caused by a mutation in the hypocretin (orexin) receptor 2 gene","volume":"98","author":"Lin","year":"1999","journal-title":"Cell"},{"issue":"8","key":"10.1016\/bs.acc.2022.03.006_bb0050","doi-asserted-by":"crossref","first-page":"3106","DOI":"10.1523\/JNEUROSCI.23-08-03106.2003","article-title":"Involvement of the lateral hypothalamic peptide orexin in morphine dependence and withdrawal","volume":"23","author":"Georgescu","year":"2003","journal-title":"J. Neurosci."},{"issue":"4","key":"10.1016\/bs.acc.2022.03.006_bb0055","doi-asserted-by":"crossref","first-page":"383","DOI":"10.31887\/DCNS.2006.8.4\/ssmith","article-title":"The role of the hypothalamic-pituitary-adrenal axis in neuroendocrine responses to stress","volume":"8","author":"Smith","year":"2006","journal-title":"Dialogues Clin. Neurosci."},{"issue":"3","key":"10.1016\/bs.acc.2022.03.006_bb0060","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1016\/S0896-6273(00)00058-1","article-title":"Reduced number of hypocretin neurons in human narcolepsy","volume":"27","author":"Thannickal","year":"2000","journal-title":"Neuron"},{"issue":"9197","key":"10.1016\/bs.acc.2022.03.006_bb0065","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/S0140-6736(99)05582-8","article-title":"Hypocretin (orexin) deficiency in human narcolepsy","volume":"355","author":"Nishino","year":"2000","journal-title":"Lancet"},{"issue":"3","key":"10.1016\/bs.acc.2022.03.006_bb0070","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1002\/ana.1130","article-title":"Low cerebrospinal fluid hypocretin (orexin) and altered energy homeostasis in human narcolepsy","volume":"50","author":"Nishino","year":"2001","journal-title":"Ann. Neurol."},{"key":"10.1016\/bs.acc.2022.03.006_bb0075","series-title":"Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition (DSM-5)","author":"American Psychiatric Association","year":"2013"},{"issue":"2","key":"10.1016\/bs.acc.2022.03.006_bb0080","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1111\/j.1440-1819.2003.01204.x","article-title":"Schizophrenia and narcolepsy: a review with a case report","volume":"58","author":"Kishi","year":"2004","journal-title":"Psychiatry Clin. Neurosci."},{"issue":"4","key":"10.1016\/bs.acc.2022.03.006_bb0085","first-page":"30","article-title":"Narcolepsy presenting as schizophrenia: a literature review and two case reports","volume":"8","author":"Talih","year":"2011","journal-title":"Innov. Clin. Neurosci."},{"issue":"1","key":"10.1016\/bs.acc.2022.03.006_bb0090","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/j.genhosppsych.2009.08.007","article-title":"Anxiety and mood disorders in narcolepsy: a case-control study","volume":"32","author":"Fortuyn","year":"2010","journal-title":"Gen. Hosp. Psychiatry"},{"issue":"6","key":"10.1016\/bs.acc.2022.03.006_bb0095","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1016\/j.sleep.2013.03.002","article-title":"Narcolepsy is complicated by high medical and psychiatric comorbidities: a comparison with the general population","volume":"14","author":"Ohayon","year":"2013","journal-title":"Sleep Med."},{"issue":"1","key":"10.1016\/bs.acc.2022.03.006_bb0100","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0165-1781(02)00032-X","article-title":"CSF hypocretin-1 levels in schizophrenics and controls: relationship to sleep architecture","volume":"110","author":"Nishino","year":"2002","journal-title":"Psychiatry Res."},{"key":"10.1016\/bs.acc.2022.03.006_bb0105","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1186\/s12888-016-0859-9","article-title":"Exploring the presence of narcolepsy in patients with schizophrenia","volume":"16","author":"Sansa","year":"2016","journal-title":"BMC Psychiatry"},{"issue":"7","key":"10.1016\/bs.acc.2022.03.006_bb0110","doi-asserted-by":"crossref","first-page":"1001","DOI":"10.1016\/j.psyneuen.2010.01.001","article-title":"Low cerebrospinal fluid and plasma orexin-A (hypocretin-1) concentrations in combat-related posttraumatic stress disorder","volume":"35","author":"Strawn","year":"2010","journal-title":"Psychoneuroendocrinology"},{"key":"10.1016\/bs.acc.2022.03.006_bb0115","doi-asserted-by":"crossref","first-page":"710","DOI":"10.3389\/fendo.2018.00710","article-title":"Plasma orexin-A levels do not undergo circadian rhythm in young healthy male subjects","volume":"9","author":"Makela","year":"2018","journal-title":"Front. Endocrinol. (Lausanne)."},{"issue":"3","key":"10.1016\/bs.acc.2022.03.006_bb0120","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1016\/j.regpep.2004.02.004","article-title":"Pharmacokinetic profile of orexin A and effects on plasma insulin and glucagon in the rat","volume":"119","author":"Ehrstrom","year":"2004","journal-title":"Regul. Pept."},{"issue":"3","key":"10.1016\/bs.acc.2022.03.006_bb0125","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1097\/YIC.0b013e3283377850","article-title":"Plasma orexin A, ghrelin, cholecystokinin, visfatin, leptin and agouti-related protein levels during 6-week olanzapine treatment in first-episode male patients with psychosis","volume":"25","author":"Basoglu","year":"2010","journal-title":"Int. Clin. Psychopharmacol."},{"key":"10.1016\/bs.acc.2022.03.006_bb0130","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1016\/j.psyneuen.2015.11.013","article-title":"Diurnal neurobiological alterations after exposure to clozapine in first-episode schizophrenia patients","volume":"64","author":"Sun","year":"2016","journal-title":"Psychoneuroendocrinology"},{"key":"10.1016\/bs.acc.2022.03.006_bb0135","doi-asserted-by":"crossref","first-page":"2221","DOI":"10.2147\/NDT.S209023","article-title":"Reduced plasma orexin-A levels in patients with bipolar disorder","volume":"15","author":"Tsuchimine","year":"2019","journal-title":"Neuropsychiatr. Dis. Treat."},{"key":"10.1016\/bs.acc.2022.03.006_bb0140","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1016\/j.neubiorev.2019.05.018","article-title":"Appetite regulating hormones in first-episode psychosis: A systematic review and meta-analysis","volume":"102","author":"Misiak","year":"2019","journal-title":"Neurosci. Biobehav. Rev."},{"key":"10.1016\/bs.acc.2022.03.006_bb0145","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.psyneuen.2014.12.012","article-title":"Elevated plasma orexin a levels in a subgroup of patients with schizophrenia associated with fewer negative and disorganized symptoms","volume":"53","author":"Chien","year":"2015","journal-title":"Psychoneuroendocrinology"},{"key":"10.1016\/bs.acc.2022.03.006_bb0150","doi-asserted-by":"crossref","DOI":"10.1093\/schbul\/sbab042","article-title":"Changes of Hypocretin (orexin) system in schizophrenia: from plasma to brain","author":"Lu","year":"2021","journal-title":"Schizophr. Bull."},{"issue":"1","key":"10.1016\/bs.acc.2022.03.006_bb0155","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.sleep.2013.09.018","article-title":"Narcolepsy-cataplexy and schizophrenia in adolescents","volume":"15","author":"Huang","year":"2014","journal-title":"Sleep Med."},{"issue":"Suppl 2","key":"10.1016\/bs.acc.2022.03.006_bb0160","doi-asserted-by":"crossref","first-page":"S94","DOI":"10.1007\/s10198-002-0113-x","article-title":"Narcoleptic and schizophrenic hallucinations. Implications for differential diagnosis and pathophysiology","volume":"3","author":"Dahmen","year":"2002","journal-title":"Eur. J. Health Econ."},{"key":"10.1016\/bs.acc.2022.03.006_bb0165","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1016\/j.phrs.2015.07.022","article-title":"Metabolic syndrome and obesity among users of second generation antipsychotics: a global challenge for modern psychopharmacology","volume":"101","author":"Rojo","year":"2015","journal-title":"Pharmacol. Res."},{"issue":"15","key":"10.1016\/bs.acc.2022.03.006_bb0170","doi-asserted-by":"crossref","first-page":"6742","DOI":"10.1523\/JNEUROSCI.22-15-06742.2002","article-title":"Differential activation of orexin neurons by antipsychotic drugs associated with weight gain","volume":"22","author":"Fadel","year":"2002","journal-title":"J. Neurosci."},{"issue":"5","key":"10.1016\/bs.acc.2022.03.006_bb0175","doi-asserted-by":"crossref","first-page":"507","DOI":"10.33549\/physiolres.930516","article-title":"Clozapine blocks sympathetic and thermogenic reactions induced by orexin A in rat","volume":"53","author":"Monda","year":"2004","journal-title":"Physiol. Res."},{"issue":"10","key":"10.1016\/bs.acc.2022.03.006_bb0180","doi-asserted-by":"crossref","first-page":"836","DOI":"10.1038\/sj.mp.4001363","article-title":"Lower CSF orexin A (hypocretin-1) levels in patients with schizophrenia treated with haloperidol compared to unmedicated subjects","volume":"8","author":"Dalal","year":"2003","journal-title":"Mol. Psychiatry"},{"issue":"1","key":"10.1016\/bs.acc.2022.03.006_bb0185","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1093\/ijnp\/pyy075","article-title":"Orexin-A levels in relation to the risk of metabolic syndrome in patients with schizophrenia taking antipsychotics","volume":"22","author":"Chen","year":"2019","journal-title":"Int. J. Neuropsychopharmacol."},{"issue":"1\u20133","key":"10.1016\/bs.acc.2022.03.006_bb0190","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1016\/j.schres.2014.06.001","article-title":"Brain circuit dysfunction in a distinct subset of chronic psychotic patients","volume":"157","author":"Goldman","year":"2014","journal-title":"Schizophr. Res."},{"issue":"2\u20133","key":"10.1016\/bs.acc.2022.03.006_bb0195","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1016\/j.schres.2008.09.029","article-title":"Mortality over a 20-year period in patients with primary polydipsia associated with schizophrenia: a retrospective study","volume":"107","author":"Hawken","year":"2009","journal-title":"Schizophr. Res."},{"key":"10.1016\/bs.acc.2022.03.006_bb0200","doi-asserted-by":"crossref","DOI":"10.1016\/j.pnpbp.2019.109756","article-title":"Relationship between polydipsia and antipsychotics: a systematic review of clinical studies and case reports","volume":"96","author":"Kirino","year":"2020","journal-title":"Prog. Neuropsychopharmacol. Biol. Psychiatry"},{"issue":"3","key":"10.1016\/bs.acc.2022.03.006_bb0205","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1007\/s00213-010-1909-5","article-title":"Opposite roles of dopamine and orexin in quinpirole-induced excessive drinking: a rat model of psychotic polydipsia","volume":"211","author":"Milella","year":"2010","journal-title":"Psychopharmacology (Berl)"},{"issue":"4","key":"10.1016\/bs.acc.2022.03.006_bb0210","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1007\/s00424-012-1080-4","article-title":"The osmotically and histamine-induced enhancement of the plasma vasopressin level is diminished by intracerebroventricularly administered orexin in rats","volume":"463","author":"Kis","year":"2012","journal-title":"Pflugers Arch."},{"issue":"5","key":"10.1016\/bs.acc.2022.03.006_bb0215","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1016\/j.biopsych.2005.04.015","article-title":"Association of an orexin 1 receptor 408Val variant with polydipsia-hyponatremia in schizophrenic subjects","volume":"58","author":"Meerabux","year":"2005","journal-title":"Biol. Psychiatry"},{"issue":"4","key":"10.1016\/bs.acc.2022.03.006_bb0220","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1007\/s12017-007-8001-2","article-title":"The orexin 1 receptor (HCRTR1) gene as a susceptibility gene contributing to polydipsia-hyponatremia in schizophrenia","volume":"9","author":"Fukunaka","year":"2007","journal-title":"Neuromolecular Med."},{"issue":"3","key":"10.1016\/bs.acc.2022.03.006_bb0225","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1097\/00001756-200103050-00008","article-title":"Orexin A immunoreactivity and preproorexin mRNA in the brain of Zucker and WKY rats","volume":"12","author":"Taheri","year":"2001","journal-title":"Neuroreport"},{"issue":"5","key":"10.1016\/bs.acc.2022.03.006_bb0230","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1016\/j.npep.2007.04.006","article-title":"Effects of rapid eye movement sleep deprivation on hypocretin neurons in the hypothalamus of a rat model of depression","volume":"41","author":"Allard","year":"2007","journal-title":"Neuropeptides"},{"issue":"5","key":"10.1016\/bs.acc.2022.03.006_bb0235","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1016\/j.npep.2004.06.004","article-title":"Stereological analysis of the hypothalamic hypocretin\/orexin neurons in an animal model of depression","volume":"38","author":"Allard","year":"2004","journal-title":"Neuropeptides"},{"issue":"1","key":"10.1016\/bs.acc.2022.03.006_bb0240","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1111\/acps.13253","article-title":"Sleep deprivation as treatment for depression: systematic review and meta-analysis","volume":"143","author":"Ioannou","year":"2021","journal-title":"Acta Psychiatr. Scand."},{"issue":"6","key":"10.1016\/bs.acc.2022.03.006_bb0245","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1016\/j.npep.2011.07.010","article-title":"Increased numbers of orexin\/hypocretin neurons in a genetic rat depression model","volume":"45","author":"Mikrouli","year":"2011","journal-title":"Neuropeptides"},{"issue":"7","key":"10.1016\/bs.acc.2022.03.006_bb0250","doi-asserted-by":"crossref","first-page":"784","DOI":"10.1177\/0269881106082899","article-title":"Changes in brain orexin levels in a rat model of depression induced by neonatal administration of clomipramine","volume":"22","author":"Feng","year":"2008","journal-title":"J. Psychopharmacol."},{"key":"10.1016\/bs.acc.2022.03.006_bb0255","doi-asserted-by":"crossref","first-page":"244","DOI":"10.3389\/fnbeh.2014.00244","article-title":"Exercise reverses the effects of early life stress on orexin cell reactivity in male but not female rats","volume":"8","author":"James","year":"2014","journal-title":"Front Behav. Neurosci."},{"issue":"12","key":"10.1016\/bs.acc.2022.03.006_bb0260","doi-asserted-by":"crossref","first-page":"3071","DOI":"10.1523\/JNEUROSCI.5584-07.2008","article-title":"Orexin signaling mediates the antidepressant-like effect of calorie restriction","volume":"28","author":"Lutter","year":"2008","journal-title":"J. Neurosci."},{"key":"10.1016\/bs.acc.2022.03.006_bb0265","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1016\/j.neuroscience.2012.05.033","article-title":"The social defeat animal model of depression shows diminished levels of orexin in mesocortical regions of the dopamine system, and of dynorphin and orexin in the hypothalamus","volume":"218","author":"Nocjar","year":"2012","journal-title":"Neuroscience"},{"issue":"2","key":"10.1016\/bs.acc.2022.03.006_bb0270","doi-asserted-by":"crossref","DOI":"10.1523\/ENEURO.0273-17.2018","article-title":"Reduced orexin system function contributes to resilience to repeated social stress","volume":"5","author":"Grafe","year":"2018","journal-title":"eNeuro."},{"issue":"1\u20132","key":"10.1016\/bs.acc.2022.03.006_bb0275","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1016\/j.neuropharm.2011.04.022","article-title":"Activation of orexin neurons in dorsomedial\/perifornical hypothalamus and antidepressant reversal in a rodent model of depression","volume":"61","author":"Nollet","year":"2011","journal-title":"Neuropharmacology"},{"key":"10.1016\/bs.acc.2022.03.006_bb0280","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1016\/j.ebiom.2017.03.043","article-title":"Sexually dimorphic changes of Hypocretin (orexin) in depression","volume":"18","author":"Lu","year":"2017","journal-title":"EBioMedicine"},{"key":"10.1016\/bs.acc.2022.03.006_bb0285","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/j.nbd.2015.04.004","article-title":"Antidepressant effects of exercise are produced via suppression of hypocretin\/orexin and melanin-concentrating hormone in the basolateral amygdala","volume":"79","author":"Kim","year":"2015","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/bs.acc.2022.03.006_bb0290","doi-asserted-by":"crossref","DOI":"10.1016\/j.npep.2020.102019","article-title":"Involvement of orexin-A in the regulation of neuronal activity and emotional behaviors in central amygdala in rats","volume":"80","author":"Pan","year":"2020","journal-title":"Neuropeptides"},{"issue":"2","key":"10.1016\/bs.acc.2022.03.006_bb0295","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1038\/s41380-018-0127-0","article-title":"Orexin prevents depressive-like behavior by promoting stress resilience","volume":"24","author":"Ji","year":"2019","journal-title":"Mol. Psychiatry"},{"key":"10.1016\/bs.acc.2022.03.006_bb0300","doi-asserted-by":"crossref","DOI":"10.1016\/j.bbr.2020.112866","article-title":"Orexin A injection into the ventral medial prefrontal cortex induces antidepressant-like effects: possible involvement of local Orexin-1 and Trk receptors","volume":"395","author":"Stanquini","year":"2020","journal-title":"Behav. Brain Res."},{"issue":"1","key":"10.1016\/bs.acc.2022.03.006_bb0305","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1037\/a0031442","article-title":"Depressive behavior and activation of the orexin\/hypocretin system","volume":"127","author":"Arendt","year":"2013","journal-title":"Behav. Neurosci."},{"key":"10.1016\/bs.acc.2022.03.006_bb0310","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1016\/j.bbr.2014.05.030","article-title":"Increased number of orexin\/hypocretin neurons with high and prolonged external stress-induced depression","volume":"272","author":"Jalewa","year":"2014","journal-title":"Behav. Brain Res."},{"key":"10.1016\/bs.acc.2022.03.006_bb0315","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1016\/j.neuroscience.2014.04.069","article-title":"Attenuated orexinergic signaling underlies depression-like responses induced by daytime light deficiency","volume":"272","author":"Deats","year":"2014","journal-title":"Neuroscience"},{"issue":"2","key":"10.1016\/bs.acc.2022.03.006_bb0320","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1016\/j.bbr.2011.02.044","article-title":"Hcrtr1 and 2 signaling differentially regulates depression-like behaviors","volume":"222","author":"Scott","year":"2011","journal-title":"Behav. Brain Res."},{"key":"10.1016\/bs.acc.2022.03.006_bb0325","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1016\/j.biopha.2018.10.033","article-title":"Co-administration of the low dose of orexin and nitrergic antagonists induces an antidepressant-like effect in mice","volume":"109","author":"Alijanpour","year":"2019","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/bs.acc.2022.03.006_bb0330","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.psyneuen.2013.10.010","article-title":"Anxiolytic function of the orexin 2\/hypocretin A receptor in the basolateral amygdala","volume":"40","author":"Arendt","year":"2014","journal-title":"Psychoneuroendocrinology"},{"issue":"2","key":"10.1016\/bs.acc.2022.03.006_bb0335","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1007\/s11011-017-0123-0","article-title":"Chronic light exposure alters serotonergic and orexinergic systems in the rat brain and reverses maternal separation-induced increase in orexin receptors in the prefrontal cortex","volume":"33","author":"Dimatelis","year":"2018","journal-title":"Metab. Brain Dis."},{"key":"10.1016\/bs.acc.2022.03.006_bb0340","doi-asserted-by":"crossref","first-page":"324","DOI":"10.3389\/fnbeh.2015.00324","article-title":"Comprehensive behavioral analysis of male Ox1r (\u2212\/\u2212) mice showed implication of orexin Receptor-1 in mood, anxiety, and social behavior","volume":"9","author":"Abbas","year":"2015","journal-title":"Front Behav Neurosci."},{"key":"10.1016\/bs.acc.2022.03.006_bb0345","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/j.neuropharm.2018.09.016","article-title":"Orexin 2 receptor stimulation enhances resilience, while orexin 2 inhibition promotes susceptibility, to social stress, anxiety and depression","volume":"143","author":"Staton","year":"2018","journal-title":"Neuropharmacology"},{"key":"10.1016\/bs.acc.2022.03.006_bb0350","doi-asserted-by":"crossref","DOI":"10.1016\/j.yhbeh.2019.104584","article-title":"Orexinergic modulation of serotonin neurons in the dorsal raphe of a diurnal rodent, Arvicanthis niloticus","volume":"116","author":"Adidharma","year":"2019","journal-title":"Horm. Behav."},{"issue":"9","key":"10.1016\/bs.acc.2022.03.006_bb0355","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1016\/j.euroneuro.2007.01.005","article-title":"Reduced orexin levels in the cerebrospinal fluid of suicidal patients with major depressive disorder","volume":"17","author":"Brundin","year":"2007","journal-title":"Eur. Neuropsychopharmacol."},{"issue":"1","key":"10.1016\/bs.acc.2022.03.006_bb0360","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1038\/nm.2075","article-title":"A key role for orexin in panic anxiety","volume":"16","author":"Johnson","year":"2010","journal-title":"Nat. Med."},{"issue":"1\u20132","key":"10.1016\/bs.acc.2022.03.006_bb0365","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/j.jad.2008.04.011","article-title":"Increased orexin levels in the cerebrospinal fluid the first year after a suicide attempt","volume":"113","author":"Brundin","year":"2009","journal-title":"J. Affect. Disord."},{"issue":"1\u20133","key":"10.1016\/bs.acc.2022.03.006_bb0370","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1016\/j.jad.2006.10.019","article-title":"Orexin and psychiatric symptoms in suicide attempters","volume":"100","author":"Brundin","year":"2007","journal-title":"J. Affect. Disord."},{"issue":"2\u20133","key":"10.1016\/bs.acc.2022.03.006_bb0375","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1016\/j.psychres.2011.06.004","article-title":"CSF-hypocretin-1 levels in patients with major depressive disorder compared to healthy controls","volume":"190","author":"Schmidt","year":"2011","journal-title":"Psychiatry Res."},{"issue":"1","key":"10.1016\/bs.acc.2022.03.006_bb0380","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1016\/j.neulet.2010.07.038","article-title":"Cerebrospinal fluid hypocretin-1 (orexin A) levels in mania compared to unipolar depression and healthy controls","volume":"483","author":"Schmidt","year":"2010","journal-title":"Neurosci. Lett."},{"issue":"2","key":"10.1016\/bs.acc.2022.03.006_bb0385","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1016\/S0006-3223(02)01740-7","article-title":"Diurnal variation of cerebrospinal fluid hypocretin-1 (orexin-A) levels in control and depressed subjects","volume":"54","author":"Salomon","year":"2003","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/bs.acc.2022.03.006_bb0390","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1016\/j.jad.2020.08.024","article-title":"Linking peripheral IL-6, IL-1beta and hypocretin-1 with cognitive impairment from major depression","volume":"277","author":"Jin","year":"2020","journal-title":"J. Affect. Disord."},{"issue":"3","key":"10.1016\/bs.acc.2022.03.006_bb0395","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1080\/17470919.2016.1169216","article-title":"Relationship between orexin A and childhood maltreatment in female patients with depression and anxiety","volume":"12","author":"Ozsoy","year":"2017","journal-title":"Soc. Neurosci."},{"issue":"1\u20133","key":"10.1016\/bs.acc.2022.03.006_bb0400","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1016\/j.jad.2010.12.004","article-title":"Orexin expression and promoter-methylation in peripheral blood of patients suffering from major depressive disorder","volume":"131","author":"Rotter","year":"2011","journal-title":"J. Affect. Disord."},{"issue":"2","key":"10.1016\/bs.acc.2022.03.006_bb0405","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1080\/13651501.2018.1551549","article-title":"Orexin\/hypocretin receptor, Orx1, gene variants are associated with major depressive disorder","volume":"23","author":"Cengiz","year":"2019","journal-title":"Int. J. Psychiatry Clin. Pract."},{"issue":"3","key":"10.1016\/bs.acc.2022.03.006_bb0410","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1016\/j.jad.2010.10.033","article-title":"Association between major mood disorders and the hypocretin receptor 1 gene","volume":"130","author":"Rainero","year":"2011","journal-title":"J. Affect. Disord."},{"key":"10.1016\/bs.acc.2022.03.006_bb0415","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1016\/j.neubiorev.2020.07.040","article-title":"Dysregulation of the orexinergic system: a potential neuropeptide target in depression","volume":"118","author":"Khairuddin","year":"2020","journal-title":"Neurosci. Biobehav. Rev."},{"issue":"10","key":"10.1016\/bs.acc.2022.03.006_bb0420","doi-asserted-by":"crossref","first-page":"2210","DOI":"10.1038\/npp.2012.70","article-title":"Neurogenesis-independent antidepressant-like effects on behavior and stress axis response of a dual orexin receptor antagonist in a rodent model of depression","volume":"37","author":"Nollet","year":"2012","journal-title":"Neuropsychopharmacology"},{"issue":"10","key":"10.1016\/bs.acc.2022.03.006_bb0425","doi-asserted-by":"crossref","first-page":"1716","DOI":"10.1248\/bpb.32.1716","article-title":"A possible mechanism underlying an antidepressive-like effect of Kososan, a Kampo medicine, via the hypothalamic orexinergic system in the stress-induced depression-like model mice","volume":"32","author":"Ito","year":"2009","journal-title":"Biol. Pharm. Bull."},{"key":"10.1016\/bs.acc.2022.03.006_bb0430","doi-asserted-by":"crossref","first-page":"1121","DOI":"10.2147\/NDT.S250141","article-title":"Orexin\/Hypocretin type 2 receptor (HCRTR2) gene as a candidate gene in sertraline-associated insomnia in depressed patients","volume":"16","author":"Firouzabadi","year":"2020","journal-title":"Neuropsychiatr. Dis. Treat."},{"issue":"1","key":"10.1016\/bs.acc.2022.03.006_bb0435","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1038\/s41398-019-0553-z","article-title":"The selective orexin-2 antagonist seltorexant (JNJ-42847922\/MIN-202) shows antidepressant and sleep-promoting effects in patients with major depressive disorder","volume":"9","author":"Recourt","year":"2019","journal-title":"Transl. Psychiatry"},{"issue":"2","key":"10.1016\/bs.acc.2022.03.006_bb0440","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1177\/0269881118822258","article-title":"The selective orexin-2 receptor antagonist seltorexant improves sleep: an exploratory double-blind, placebo controlled, crossover study in antidepressant-treated major depressive disorder patients with persistent insomnia","volume":"33","author":"Brooks","year":"2019","journal-title":"J. Psychopharmacol."},{"issue":"3","key":"10.1016\/bs.acc.2022.03.006_bb0445","doi-asserted-by":"crossref","first-page":"402","DOI":"10.4306\/pi.2015.12.3.402","article-title":"CDH13 and HCRTR2 may be associated with hypersomnia symptom of bipolar depression: a genome-wide functional enrichment pathway analysis","volume":"12","author":"Cho","year":"2015","journal-title":"Psychiatry Investig."},{"issue":"8\u20139","key":"10.1016\/bs.acc.2022.03.006_bb0450","doi-asserted-by":"crossref","first-page":"1127","DOI":"10.1016\/S0531-5565(02)00092-X","article-title":"Age-related changes in plasma orexin-A concentrations","volume":"37","author":"Matsumura","year":"2002","journal-title":"Exp. Gerontol."},{"issue":"1","key":"10.1016\/bs.acc.2022.03.006_bb0455","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1038\/s41398-020-0698-9","article-title":"Significance of the orexinergic system in modulating stress-related responses in an animal model of post-traumatic stress disorder","volume":"10","author":"Cohen","year":"2020","journal-title":"Transl. Psychiatry"},{"issue":"2","key":"10.1016\/bs.acc.2022.03.006_bb0460","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1080\/13651501.2019.1711425","article-title":"Orexin A in adolescents with anxiety disorders","volume":"24","author":"Akca","year":"2020","journal-title":"Int. J. Psychiatry Clin. Pract."},{"issue":"5","key":"10.1016\/bs.acc.2022.03.006_bb0465","doi-asserted-by":"crossref","first-page":"644","DOI":"10.1016\/j.yhbeh.2011.08.017","article-title":"Involvement of orexin in the regulation of stress, depression and reward in alcohol dependence","volume":"60","author":"von der Goltz","year":"2011","journal-title":"Horm. Behav."},{"issue":"2","key":"10.1016\/bs.acc.2022.03.006_bb0470","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1111\/j.1460-9568.2009.07065.x","article-title":"The hypocretin-orexin system regulates cocaine self-administration via actions on the mesolimbic dopamine system","volume":"31","author":"Espana","year":"2010","journal-title":"Eur. J. Neurosci."},{"key":"10.1016\/bs.acc.2022.03.006_bb0475","doi-asserted-by":"crossref","DOI":"10.1016\/j.brainres.2019.146359","article-title":"Preliminary examination of the orexin system on relapse-related factors in cocaine use disorder","volume":"1731","author":"Suchting","year":"2020","journal-title":"Brain Res."},{"issue":"1","key":"10.1016\/bs.acc.2022.03.006_bb0480","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1007\/s00213-019-05342-9","article-title":"Chronic ketamine abuse is associated with orexin-A reduction and ACTH elevation","volume":"237","author":"Huang","year":"2020","journal-title":"Psychopharmacology (Berl)"},{"key":"10.1016\/bs.acc.2022.03.006_bb0485","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1016\/j.psychres.2018.04.010","article-title":"Orexin A in men with heroin use disorder undergoing methadone maintenance treatment","volume":"264","author":"Tsai","year":"2018","journal-title":"Psychiatry Res."},{"key":"10.1016\/bs.acc.2022.03.006_bb0490","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1186\/s13041-015-0142-x","article-title":"Associations between the orexin (hypocretin) receptor 2 gene polymorphism Val308Ile and nicotine dependence in genome-wide and subsequent association studies","volume":"8","author":"Nishizawa","year":"2015","journal-title":"Mol. Brain"},{"issue":"2","key":"10.1016\/bs.acc.2022.03.006_bb0495","first-page":"134","article-title":"Brain-derived neurotrophic factor and mental disorders","volume":"43","author":"Lin","year":"2020","journal-title":"Biom. J."},{"issue":"5","key":"10.1016\/bs.acc.2022.03.006_bb0500","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1080\/15622975.2016.1224925","article-title":"Serum brain-derived neurotrophic factors in Taiwanese patients with drug-naive first-episode schizophrenia: effects of antipsychotics","volume":"18","author":"Chiou","year":"2017","journal-title":"World J. Biol. Psychiatry"},{"issue":"3","key":"10.1016\/bs.acc.2022.03.006_bb0505","first-page":"213","article-title":"Serum brain-derived neurotrophic factors in Taiwanese patients with drug-naive first-episode major depressive disorder: effects of antidepressants","volume":"20","author":"Chiou","year":"2017","journal-title":"Int. J. Neuropsychopharmacol."},{"issue":"4","key":"10.1016\/bs.acc.2022.03.006_bb0510","first-page":"272","article-title":"Brain-derived neurotrophic factor protein and mRNA levels in patients with bipolar mania\u2014a preliminary study","volume":"39","author":"Lin","year":"2016","journal-title":"Biom. J."},{"key":"10.1016\/bs.acc.2022.03.006_bb0515","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.smrv.2016.09.004","article-title":"Suvorexant for the treatment of primary insomnia: a systematic review and meta-analysis","volume":"35","author":"Kuriyama","year":"2017","journal-title":"Sleep Med. Rev."},{"key":"10.1016\/bs.acc.2022.03.006_bb0520","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1016\/j.pnpbp.2019.01.016","article-title":"Insomnia in patients with schizophrenia: current understanding and treatment options","volume":"92","author":"Robertson","year":"2019","journal-title":"Prog. Neuropsychopharmacol. Biol. Psychiatry"}],"container-title":["Advances in Clinical Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0065242322000312?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0065242322000312?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,4]],"date-time":"2025-11-04T04:07:50Z","timestamp":1762229270000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0065242322000312"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022]]},"ISBN":["9780323988513"],"references-count":103,"URL":"https:\/\/doi.org\/10.1016\/bs.acc.2022.03.006","relation":{},"ISSN":["0065-2423"],"issn-type":[{"value":"0065-2423","type":"print"}],"subject":[],"published":{"date-parts":[[2022]]}}}